Company Search:
Advanced Search
Sponsored Links
Canntab Therapeutics Ltd Company Snapshot
Canntab Therapeutics Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Canntab Therapeutics Ltd with three other companies in this sector in Canada: Cronos Group Inc (2016 sales of 554,203.00 Canadian Dollars [US$418,583.98 ] ), Emblem Corp (276,907.00 Canadian Dollars [US$209,145.09 ] ), and Aurora Cannabis Inc (1.44 million Canadian Dollars [US$1.09 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Canntab Therapeutics Ltd
  Stock Performance Chart for Canntab Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 1.35
(Figures in Canadian Dollars)
1 Week 8.0%   13 Weeks -21.5%  
4 Weeks 125.0%   52 Weeks n/a  
Canntab Therapeutics Ltd Key Data:
  Ticker: PILL Country: Canada
  Exchanges: MON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 907,634
(Year Ending Jan 2017).
Employees: 10
  Currency: Canadian Dollars Market Cap: 34,134,346
  Fiscal Yr Ends: December Shares Outstanding: 25,284,701
  Share Type: Common Closely Held Shares: 8,360,334
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.